An Integrated Systems Biology Approach Identifies the Proteasome as A Critical Host Machinery for ZIKV and DENV Replication
- Author:
Song GUANG
1
;
M.Lee EMILY
;
Pan JIANBO
;
Xu MIAO
;
Rho HEE-SOOL
;
Cheng YICHEN
;
Whitt NADIA
;
Yang SHU
;
Kouznetsova JENNIFER
;
Klumpp-Thomas CARLEEN
;
G.Michael SAMUEL
;
Moore CEDRIC
;
Yoon KI-JUN
;
M.Christian KIMBERLY
;
Simeonov ANTON
;
Huang WENWEI
;
Xia MENGHANG
;
Huang RUILI
;
Lal-Nag MADHU
;
Tang HENGLI
;
Zheng WEI
;
Qian JIANG
;
Song HONGJUN
;
Ming GUO-LI
;
Zhu HENG
Author Information
1. Department of Pharmacology&Molecular Sciences,Johns Hopkins School of Medicine,Baltimore,MD 21205,USA
- Keywords:
Protein–protein interaction;
RNAi screening;
Chemical genetics screening;
Multi-omics
- From:
Genomics, Proteomics & Bioinformatics
2021;19(1):108-122
- CountryChina
- Language:Chinese
-
Abstract:
The Zika virus (ZIKV) and dengue virus (DENV) flaviviruses exhibit similar replicative processes but have distinct clinical outcomes. A systematic understanding of virus–host protein–pro-tein interaction networks can reveal cellular pathways critical to viral replication and disease patho-genesis. Here we employed three independent systems biology approaches toward this goal. First, protein array analysis of direct interactions between individual ZIKV/DENV viral proteins and 20,240 human proteins revealed multiple conserved cellular pathways and protein complexes, including proteasome complexes. Second, an RNAi screen of 10,415 druggable genes identified the host proteins required for ZIKV infection and uncovered that proteasome proteins were crucial in this process. Third, high-throughput screening of 6016 bioactive compounds for ZIKV inhibition yielded 134 effective compounds, including six proteasome inhibitors that suppress both ZIKV and DENV replication. Integrative analyses of these orthogonal datasets pinpoint proteasomes as crit-ical host machinery for ZIKV/DENV replication. Our study provides multi-omics datasets for fur-ther studies of flavivirus–host interactions, disease pathogenesis, and new drug targets.
